Antitrust Antitrust

US FTC’s Khan disappointed after commission rejects move to investigate pharmacy benefit managers’ drug pricing, contracts

By Khushita Vasant
  • 17 Feb 2022 17:59
  • 17 Feb 2022 18:53
US Federal Trade Commission chair Lina Khan today said she was “really disappointed” after a split agency vote led to the failure of a motion seeking to investigate pharmacy benefit managers’ drug pricing and contracting practices and their impact on competition and consumers' healthcare costs.

During the agency's monthly Open Commission Meeting,

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News